Related Experiment Video
Updated: Aug 16, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Antibiotic-Impregnated Ventriculoperitoneal Shunts Decrease Bacterial Shunt Infection: A Systematic Review and
Janka Kovács1,2, Vanda Máté1,2, Mahmoud Obeidat1
1Centre for Translational Medicine, Semmelweis University, Budapest , Hungary.
Background And Objectives:
Antibiotic-impregnated shunts seem to be beneficial in preventing bacterial infections and decreasing mortality by effectively inhibiting microbial growth in the shunt system and reducing the risk of shunt-associated infections. This study aimed to evaluate the efficacy of antibiotic-impregnated shunt catheters (AISC) in reducing the incidence of bacterial shunt infection in patients with hydrocephalus.
Methods:
The protocol was registered on PROSPERO. A meta-analysis was conducted by searching 3 databases (PubMed, Scopus, CENTRAL) for relevant randomized controlled trials and observational studies. We included all studies published until November 2022 in any language. The primary outcome was the rate of bacterial infections, whereas the rate of shunt failure was our secondary endpoint. Odds ratios (OR) with 95% CI were calculated using a random-effects model.
Results:
A total of 27 articles with 27 266 shunt operations were included in this study. The results indicated that using AISC is significantly associated with reduction in infections (OR = 0.42; 95% CI: 0.33-0.54). Regarding shunt failure, there was a tendency in favor of AISC use (OR = 0.73; 95% CI: 0.51-1.06).
Conclusion:
Our study provided evidence that AISC is significantly associated with the reduction in the rate of bacterial ventriculoperitoneal-shunt infection. In addition, there was a tendency toward AISC to decrease shunt failure compared with the standard shunt.
Insights
Antibiotic-impregnated shunt catheters (AISCs) significantly reduce bacterial infections in hydrocephalus patients. While not statistically significant, AISCs showed a trend toward decreasing shunt failure rates compared to standard shunts.
Area of Science:
- Neurosurgery
- Infectious Disease Prevention
- Medical Device Technology
Background:
- Hydrocephalus management often involves shunt placement, which carries a risk of bacterial infection.
- Shunt-associated infections can lead to significant morbidity, mortality, and increased healthcare costs.
- Antibiotic-impregnated shunt catheters (AISCs) are designed to mitigate these risks by inhibiting microbial growth.
Approach:
- A comprehensive meta-analysis was performed, searching PubMed, Scopus, and CENTRAL databases.
- Included randomized controlled trials and observational studies published up to November 2022.
- Analyzed the primary outcome of bacterial infection rates and the secondary outcome of shunt failure rates using random-effects models.
Key Points:
- The meta-analysis included 27 articles encompassing 27,266 shunt operations.
- AISCs demonstrated a statistically significant reduction in bacterial shunt infections (OR = 0.42; 95% CI: 0.33-0.54).
- A trend favoring AISCs was observed for reducing shunt failure (OR = 0.73; 95% CI: 0.51-1.06).
Conclusions:
- AISCs are significantly effective in reducing the incidence of bacterial ventriculoperitoneal-shunt infections.
- Evidence suggests a potential benefit of AISCs in decreasing shunt failure rates.
- These findings support the use of AISCs for improved patient outcomes in hydrocephalus management.
More Related Videos
14:59Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Antimicrobial Effectiveness
Microbiota Modulation by Antibiotics